Issue 6/2022
Content (10 Articles)
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy
- Multiple Myeloma
- Leading Article
Barry Paul, Cesar Rodriguez, Saad Z. Usmani
Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals
- Selegiline
- Review Article
Fabrizio Schifano, Valeria Catalani, Safia Sharif, Flavia Napoletano, John Martin Corkery, Davide Arillotta, Suzanne Fergus, Alessandro Vento, Amira Guirguis
Targeting Acquired and Intrinsic Resistance Mechanisms in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
- NSCLC
- Review Article
Manan P. Shah, Joel W. Neal
Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review
- Open Access
- Benperidol
- Review Article
Valdemar Landgren, Josephine Savard, Cecilia Dhejne, Jussi Jokinen, Stefan Arver, Michael C. Seto, Christoffer Rahm
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis
- Daratumumab
- Adis Drug Evaluation
Hannah A. Blair
Palovarotene: First Approval
- Fibrodysplasia Ossificans Progressiva
- AdisInsight Report
Sheridan M. Hoy
Correction to: Interchangeability of Biosimilars: Overcoming the Final Hurdles
- Correction
Liese Barbier, Arnold G. Vulto